A new clinical trial is seeking dogs with severe thunderstorm aversion in Florida to evaluate an investigational oral medication that could provide the first FDA-approved treatment for this distressing veterinary behavioral condition. The study, which runs during Florida's storm season, is evaluating a twice-daily oral medication designed to offer round-the-clock relief for dogs suffering from extreme storm-related anxiety.
Addressing a Widespread Veterinary Behavioral Issue
The clinical significance of thunderstorm aversion in dogs is substantial, with published research indicating that nearly 50% of dog owners report their dogs show fear when exposed to noises. Dogs with severe thunderstorm aversion display intense behavioral symptoms including hiding, cowering, destructiveness, trembling, shaking, and self-harm. The condition can be particularly debilitating, with fear beginning hours before storms arrive and recovery sometimes taking days.
"Nothing prepared us for the thunderstorms in Florida. They're so intense and so frequent. As soon as one rolls in, she'll start panting and severely shaking. It's heartbreaking," said Marilyn Bonner, whose Boxer developed intense anxiety after moving to Florida from Pennsylvania.
Clinical Trial Design and Patient Population
The study is recruiting dogs that meet specific eligibility criteria, including demonstration of thunderstorm aversion signs, minimum weight of 8.8 pounds, and good general health status. The trial design includes a placebo-controlled component, with participating dogs receiving either the investigational medication or placebo during the study period.
Jill Powers of Southwest Florida described the severity of symptoms her dog experiences: "During a thunderstorm, my dog never leaves my side; she's there shaking, drooling, and practically hyperventilating. There are times I've thought she was going to have a heart attack."
Study Access and Regulatory Pathway
The clinical trial is being conducted across multiple veterinary clinics in Florida, with participation offered at no cost to dog owners. Qualifying dogs receive comprehensive study-related care including evaluations, diagnostic testing, examinations, and study medication or placebo without charge.
The study aims to generate data supporting approval by the FDA's Center for Veterinary Medicine, potentially establishing the first approved pharmaceutical treatment for severe thunderstorm aversion in dogs. The research is supported by Visionaire Research & Education, which specializes in patient recruitment for veterinary clinical studies.
Dog owners interested in participation can complete a pre-screening questionnaire through DogStormStudy.com to determine eligibility and locate participating veterinary sites. Given the limited duration of Florida's storm season, enrollment is time-sensitive for the current study period.
